Roche Holding AG Part. Cert.

OTC: RHHVF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Dec 1, 2021, 3:47 p.m.

/zigman2/quotes/206948568/composite

$

399.59

Change

+14.59 +3.79%

Volume

Volume 293

Quotes are delayed by 20 min

/zigman2/quotes/206948568/composite

Previous close

$ 385.00

$ 399.59

Change

+14.59 +3.79%

Day low

Day high

$391.92

$399.59

Open

52 week low

52 week high

$308.57

$411.44

Open

Insider Actions for Roche Holding AG Part. Cert.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/12/2021 Executive Officer Swiss
3,163   Disposition at $368.23 per share. 1,164,698
08/09/2021 Executive Officer Swiss
8,788   Acquisition at $362.2 per share. 3,183,013
08/09/2021 DIRECTOR Swiss Non EXECUTIVE
271   Acquisition at $394.4 per share. 106,881
07/30/2021 Executive Officer Swiss
4,317   Disposition at $350 per share. 1,510,950
07/30/2021 Executive Officer Swiss
1,116   Disposition at $350 per share. 390,600
06/22/2021 Executive Officer Swiss
500   Disposition at $374.8 per share. 187,400
06/17/2021 Executive Officer Swiss
3,000   Disposition at $348.6 per share. 1,045,800
06/17/2021 Executive Officer Swiss
2,000   Disposition at $373.13 per share. 746,250
06/11/2021 Executive Officer Swiss
500   Disposition at $366 per share. 183,000
06/08/2021 Executive Officer Swiss
4,057   Disposition at $329.94 per share. 1,338,580
05/11/2021 Executive Officer Swiss
1   Award at $0 per share. 0
05/11/2021 Executive Officer Swiss
1   Acquisition at $499,995 per share. 499,995
05/11/2021 Executive Officer Swiss
1   Acquisition at $137,490 per share. 137,490
05/11/2021 Executive Officer Swiss
1   Acquisition at $93,720 per share. 93,720
03/23/2021 Executive Officer Swiss
1,189   Disposition at $310 per share. 368,590
03/23/2021 Executive Officer Swiss
1,810   Disposition at $310 per share. 561,100
03/02/2021 Executive Officer Swiss
777   Acquisition at $304.35 per share. 236,478

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
2 Purchases
8 Sales
9,059
18,653
Last 12 months
8 Purchases
10 Sales
10,840
21,652

Officers and Executives

Dr. Severin Schwan
Chief Executive Officer & Executive Director
Dr. Alan Hippe
Chief Financial & Information Officer
Dr. Gallia G. Levy
Associate Group Medical Director-Hematology
Ms. Pascale Schmidt
Chief Compliance Officer
Dr. William Pao
Head-Pharma Research & Early Development
Mr. Per-Olof Attinger
Secretary-Executive Committee & Head-CEO Office
Dr. Karsten Jung
Global Product Strategy Head
Dr. Pablo Umaña
Head-Cancer Immunotherapy Discovery
Mr. Jason S. Ehrlich
Senior Group Medical Director
Mr. Paul Bulcke
Independent Non-Executive Director
Dr. Karl Mahler
Head-Investor Relations
Ms. Cristina A. Wilbur
Chief People Officer
Dr. Annette Luther
Secretary
Ms. Claudia Boeckstiegel
General Counsel
Dr. Christoph Franz
Chairman
Dr. Joerg Duschmale
Independent Non-Executive Director
Dr. Patrick Frost
Independent Non-Executive Director
Mr. André S. Hoffmann
Vice Chairman
Mr. Bernard J. Poussot
Independent Non-Executive Director
Dr. Richard P. Lifton
Independent Non-Executive Director
Dr. Claudia Süssmuth Dyckerhoff
Independent Non-Executive Director
Ms. Julie Brown
Independent Non-Executive Director
Ms. Anita Hauser
Independent Non-Executive Director
Dr. Hans Clevers
Independent Non-Executive Director
Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.